Overview

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to evaluate the safety and effectiveness of an investigational glaucoma therapy in patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Latanoprost
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol
Travoprost
Criteria
Inclusion Criteria:

- 18 years or older.

- Diagnosis of open-angle glaucoma (with or without pseudoexfoliation or pigment
dispersion component) or ocular hypertension.

- Mean intraocular pressure (IOP) in at least one eye greater than 21 mmHg and less than
or equal to 36 mmHg at screening visit.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Pregnant

- History of chronic or recurrent severe inflammatory eye disease.

- History of ocular infection or ocular inflammation within the past three months in
either eye.

- Other protocol-defined exclusion criteria may apply.